92 related articles for article (PubMed ID: 2873619)
21. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
22. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
[No Abstract] [Full Text] [Related]
23. [A double-blind study on the effect of clozapine penfluridol and chlorpromazine in the treatment of schizophrenia].
Bao XQ
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):274-6, 318. PubMed ID: 3069382
[No Abstract] [Full Text] [Related]
24. Clinical comparison of optical isomers L and D clorothepin, clorothepin racemate and clozapine in schizophrenic patients.
Náhunek K; Svestka J; Cesková E; Misurec J
Act Nerv Super (Praha); 1978 Dec; 20(4):276-7. PubMed ID: 367040
[No Abstract] [Full Text] [Related]
25. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
26. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO
Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979
[TBL] [Abstract][Full Text] [Related]
27. Clozapine in treatment-resistant schizophrenics.
Kane JM; Honigfeld G; Singer J; Meltzer H
Psychopharmacol Bull; 1988; 24(1):62-7. PubMed ID: 3290950
[No Abstract] [Full Text] [Related]
28. Clinical predictors of schizophrenic patient response to neuroleptics.
Korínková V
Act Nerv Super (Praha); 1989 Jun; 31(2):115-6. PubMed ID: 2572131
[No Abstract] [Full Text] [Related]
29. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Ehmann TS; Delva NJ; Beninger RJ
J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
[No Abstract] [Full Text] [Related]
31. A comparison of the clinical effects of timiperone, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.
Kariya T; Shimazono Y; Itoh H; Mori A; Murasaki M; Sugano K; Toru M; Yamashita I
J Int Med Res; 1983; 11(2):66-77. PubMed ID: 6133803
[TBL] [Abstract][Full Text] [Related]
32. Quantitative EEG, SPEM, and psychometric studies in schizophrenics before and during differential neuroleptic therapy.
Saletu B; Küfferle B; Grünberger J; Anderer P
Pharmacopsychiatry; 1986 Nov; 19(6):434-7. PubMed ID: 2879297
[No Abstract] [Full Text] [Related]
33. Antipsychotic efficacy of fluperlapine. An open multicenter trial.
Woggon B; Angst J; Bartels M; Heinrich K; Hippius H; Koukkou M; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pöldinger W
Neuropsychobiology; 1984; 11(2):116-20. PubMed ID: 6148712
[TBL] [Abstract][Full Text] [Related]
34. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
[No Abstract] [Full Text] [Related]
35. [A randomized double-blinded controlled study on treatment of schizophrenia by in vitro fostered bezoar combined with haloperidol].
Weng SH; Wang GH; Wang XP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1213-5. PubMed ID: 21275180
[No Abstract] [Full Text] [Related]
36. Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings].
Ericksen SE; Hurt SW; Chang S
Psychopharmacol Bull; 1978 Apr; 14(2):15-6. PubMed ID: 349597
[No Abstract] [Full Text] [Related]
37. Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia.
Gerlach J; Koppelhus P; Helweg E; Monrad A
Acta Psychiatr Scand; 1974; 50(4):410-24. PubMed ID: 4153596
[No Abstract] [Full Text] [Related]
38. Neuroleptic-potentiating effect of metyrosine.
Magelund G; Gerlach J; Casey DE
Am J Psychiatry; 1979 May; 136(5):732. PubMed ID: 35016
[No Abstract] [Full Text] [Related]
39. A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
Paprocki J; Barcala Peixoto MP; Andrade NM
Psychopharmacol Bull; 1976 Apr; 12(2):32-4. PubMed ID: 769026
[No Abstract] [Full Text] [Related]
40. Sertindole versus haloperidol for schizophrenia.
Balon R
Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
